Literature DB >> 24323708

Early MoCA-assessed cognitive impairment after aneurysmal subarachnoid hemorrhage and relationship to 1-year functional outcome.

George Kwok Chu Wong1, Sandy Wai Lam, Adrian Wong, Vincent Mok, Deyond Siu, Karine Ngai, Wai Sang Poon.   

Abstract

Recent clinical research into aneurysmal subarachnoid hemorrhage (aSAH) has confirmed the long-term effect of cognitive dysfunction on functional outcomes. We hypothesized that early cognitive impairment was a marker of permanent brain injury and hence predicted long-term functional outcome. Hong Kong Chinese patients with aneurysmal subarachnoid hemorrhage were evaluated prospectively by means of the Montreal Cognitive Assessment (MoCA) in the subacute phase (2-4 weeks after aSAH) and by neuropsychological evaluation of functional outcomes in the chronic phase (1 year after aSAH). This multi-center prospective observational study is registered at ClinicalTrials.gov of the US National Institutes of Health (NCT01038193). One hundred and eight patients completed both the subacute and chronic phase assessments. Cognitive dysfunction in the subacute phase independently correlated with functional outcomes at 1 year, after adjusting for age, admission clinical condition, treatment modality, motor score, and mobility in the subacute phase, but the positive predictive values remained low. MoCA-assessed cognitive impairment in the subacute phase cannot accurately predict functional outcomes at 1 year. Future study should focus on understanding the relative importance of different components of early cognitive impairment.

Entities:  

Mesh:

Year:  2013        PMID: 24323708     DOI: 10.1007/s12975-013-0284-z

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  26 in total

1.  Long-term cognitive dysfunction in patients with traumatic subarachnoid hemorrhage: prevalence and risk factors.

Authors:  George Kwok Chu Wong; Karine Ngai; Adrian Wong; Sandy Wai Lam; Vincent C T Mok; Janice Yeung; Timothy Rainer; Rosanna Wong; Wai Sang Poon
Journal:  Acta Neurochir (Wien)       Date:  2011-10-15       Impact factor: 2.216

2.  Mini-Mental State Examination versus Montreal Cognitive Assessment: rapid assessment tools for cognitive and functional outcome after aneurysmal subarachnoid hemorrhage.

Authors:  Tom A Schweizer; Timour Al-Khindi; R Loch Macdonald
Journal:  J Neurol Sci       Date:  2012-01-26       Impact factor: 3.181

3.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

Review 4.  Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis.

Authors:  Jamie L Banks; Charles A Marotta
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

5.  Brain atrophy and neuropsychological outcome after treatment of ruptured anterior cerebral artery aneurysms: a voxel-based morphometric study.

Authors:  Paula Bendel; Timo Koivisto; Eini Niskanen; Mervi Könönen; Marja Aikiä; Tuomo Hänninen; Päivi Koskenkorva; Ritva Vanninen
Journal:  Neuroradiology       Date:  2009-07-01       Impact factor: 2.804

Review 6.  Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage.

Authors:  Gabriel J E Rinkel; Ale Algra
Journal:  Lancet Neurol       Date:  2011-04       Impact factor: 44.182

7.  Brief screening tests during acute admission in patients with mild stroke are predictive of vascular cognitive impairment 3-6 months after stroke.

Authors:  YanHong Dong; Narayanaswamy Venketasubramanian; Bernard Poon-Lap Chan; Vijay Kumar Sharma; Melissa Jane Slavin; Simon Lowes Collinson; Perminder Sachdev; Yiong Huak Chan; Christopher Li-Hsian Chen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-04-11       Impact factor: 10.154

8.  Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage.

Authors:  A Hijdra; J van Gijn; N J Nagelkerke; M Vermeulen; H van Crevel
Journal:  Stroke       Date:  1988-10       Impact factor: 7.914

9.  Evaluation of cognitive impairment by the Montreal cognitive assessment in patients with aneurysmal subarachnoid haemorrhage: prevalence, risk factors and correlations with 3 month outcomes.

Authors:  George Kwok Chu Wong; Sandy Lam; Karine Ngai; Adrian Wong; Vincent Mok; W S Poon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-07-31       Impact factor: 10.154

10.  Comparison of montreal cognitive assessment and mini-mental state examination in evaluating cognitive domain deficit following aneurysmal subarachnoid haemorrhage.

Authors:  George Kwok Chu Wong; Sandy Wai Lam; Adrian Wong; Karine Ngai; Wai Sang Poon; Vincent Mok
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more
  12 in total

1.  Melatonin attenuates early brain injury after subarachnoid hemorrhage by the JAK-STAT signaling pathway.

Authors:  Shengli Li; Song Yang; Bin Sun; Chunhua Hang
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

2.  Severity-Dependent Long-Term Spatial Learning-Memory Impairment in a Mouse Model of Traumatic Brain Injury.

Authors:  Chengrui An; Xiaoyan Jiang; Hongjian Pu; Dandan Hong; Wenting Zhang; Xiaoming Hu; Yanqin Gao
Journal:  Transl Stroke Res       Date:  2016-08-18       Impact factor: 6.829

3.  Severe cognitive impairment in aneurysmal subarachnoid hemorrhage: Predictors and relationship to functional outcome.

Authors:  Joseph R Geraghty; Melissa N Lara-Angulo; Milen Spegar; Jenna Reeh; Fernando D Testai
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-06-20       Impact factor: 2.136

4.  Hypothesis on the Role of Cryptochromes in Inflammation and Subarachnoid Hemorrhage Outcome.

Authors:  Adriano Barreto Nogueira; Ariel Barreto Nogueira; José Carlos Esteves Veiga; Manoel Jacobsen Teixeira
Journal:  Front Neurol       Date:  2017-11-28       Impact factor: 4.003

5.  Validity and reliability of two alternate versions of the Montreal Cognitive Assessment (Hong Kong version) for screening of Mild Neurocognitive Disorder.

Authors:  Adrian Wong; Stanley Yiu; Ziad Nasreddine; Kam-Tat Leung; Alexander Lau; Yannie O Y Soo; Lawrence Ka-Sing Wong; Vincent Mok
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

6.  Psychometric properties of cognitive screening for patients with cerebrovascular diseases A systematic review.

Authors:  Jaqueline de Carvalho Rodrigues; Natália Becker; Carolina Luísa Beckenkamp; Camila Schorr Miná; Jerusa Fumagalli de Salles; Denise Ruschel Bandeira
Journal:  Dement Neuropsychol       Date:  2019 Jan-Mar

7.  Screening tools for early neuropsychological impairment after aneurysmal subarachnoid hemorrhage.

Authors:  Ilari M Rautalin; Martina Sebök; Menno R Germans; Miikka Korja; Noemi Dannecker; Olivia Zindel-Geisseler; Peter Brugger; Luca Regli; Martin N Stienen
Journal:  Neurol Sci       Date:  2019-12-04       Impact factor: 3.307

8.  Association of Haptoglobin Phenotype With Neurological and Cognitive Outcomes in Patients With Subarachnoid Hemorrhage.

Authors:  Sung Woo Han; Bong Jun Kim; Tae Yeon Kim; Seung Hyuk Lim; Dong Hyuk Youn; Eun Pyo Hong; Jong Kook Rhim; Jeong Jin Park; Jae Jun Lee; Yong Jun Cho; Ben Gaastra; Ian Galea; Jin Pyeong Jeon
Journal:  Front Aging Neurosci       Date:  2022-03-21       Impact factor: 5.750

Review 9.  White Matter Injury in Early Brain Injury after Subarachnoid Hemorrhage.

Authors:  Jinwei Pang; Jianhua Peng; Ping Yang; Li Kuai; Ligang Chen; John H Zhang; Yong Jiang
Journal:  Cell Transplant       Date:  2018-11-16       Impact factor: 4.064

Review 10.  Secondary White Matter Injury and Therapeutic Targets After Subarachnoid Hemorrhage.

Authors:  Xufang Ru; Ling Gao; Jiru Zhou; Qiang Li; Shilun Zuo; Yujie Chen; Zhi Liu; Hua Feng
Journal:  Front Neurol       Date:  2021-07-15       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.